Gainers
- Immutep IMMP stock rose 141.2% to $3.83 during Wednesday's regular session. Immutep's stock is trading at a volume of 53.7 million shares as of 13:30 EST. This is 57503.7% of its average full-day volume over the last 100 days. The company's market cap stands at $337.2 million.
- Motus GI Hldgs MOTS stock moved upwards by 37.22% to $0.99. Motus GI Hldgs's stock is trading at a volume of 14.7 million shares as of 13:30 EST. This is 44159.3% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $4.7 million.
- Viracta Therapeutics VIRX shares increased by 36.54% to $1.7. The current volume of 1.3 million shares is 1652.3% of Viracta Therapeutics's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $65.2 million.
- Rigel Pharmaceuticals RIGL stock rose 31.0% to $1.69. The current volume of 8.1 million shares is 305.2% of Rigel Pharmaceuticals's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $293.4 million.
- Corvus Pharma CRVS stock increased by 28.27% to $3.04. The current volume of 3.1 million shares is 589.4% of Corvus Pharma's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $141.5 million.
- X4 Pharmaceuticals XFOR stock moved upwards by 23.86% to $2.18. As of 13:30 EST, X4 Pharmaceuticals's stock is trading at a volume of 8.6 million, which is 377.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $266.4 million.
Losers
- Mallinckrodt MNK shares declined by 15.3% to $1.6 during Wednesday's regular session. Mallinckrodt's stock is trading at a volume of 80.6K shares as of 13:30 EST. This is 200.0% of its average full-day volume over the last 100 days. The company's market cap stands at $21.0 million.
- Citius Pharma CTXR shares fell 15.2% to $1.06. The current volume of 3.7 million shares is 298.0% of Citius Pharma's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $168.3 million. As per the news, the Q2 earnings report came out 3 days ago.
- Intercept Pharma ICPT stock decreased by 14.47% to $13.87. Trading volume for this security as of 13:30 EST is 4.4 million, which is 576.0% of its average full-day volume over the last 100 days. The company's market cap stands at $577.9 million.
- TScan Therapeutics TCRX stock declined by 12.54% to $3.49. As of 13:30 EST, TScan Therapeutics's stock is trading at a volume of 182.5K, which is 13.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $84.5 million.
- Cyclacel Pharmaceuticals CYCCP stock declined by 11.6% to $9.8.
- Venus Concept VERO stock decreased by 11.27% to $2.52. The company's market cap stands at $13.4 million. As per the news, the Q1 earnings report came out 2 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in